GlassScriptPhysician profile
Adonis K Hijaz
NPI 1992739528
$31,048.11
in general payments reported to CMS, 2019-2025
43 companies · $7,542 in 2025
The $7,542 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,404 · 2020: $4,200 · 2021: $1,315 · 2022: $3,030 · 2023: $4,117 · 2024: $3,440 · 2025: $7,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,205 · Food and Beverage: $5,139 · Travel and Lodging: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,204.96 |
| Food and Beverage | $5,139.03 |
| Travel and Lodging | $1,754.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $10,251.47 | 2019-2024 | Veozah, Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $8,810.40 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $2,884.77 | 2020-2024 | Axonics, Bulkamid |
| Bluewind Medical | $2,272.96 | 2024-2025 | Revi |
| Medtronic, INC. | $1,463.57 | 2021-2025 | Interstim, Altaviva, Ligasure |
| Boston Scientific Corporation | $1,275.34 | 2019-2025 | Axonics, General - Female Sui, Advantage System |
| Medtronic USA, INC. | $570.49 | 2019-2020 | |
| Allergan, INC. | $438.99 | 2019-2022 | |
| Caldera Medical, INC | $417.66 | 2021-2023 | Desara |
| Urovant Sciences INC | $321.36 | 2021-2022 | |
| Abbvie INC. | $248.82 | 2022-2025 | |
| Baxter Healthcare | $223.96 | 2020-2021 | |
| Laborie Medical Technologies Corp. | $150.46 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $148.06 | 2021-2022 | |
| Coloplast Corp | $140.87 | 2021-2023 | Altis |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adonis Hijaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.